oxidopamine and 3,6'-dithiothalidomide

oxidopamine has been researched along with 3,6'-dithiothalidomide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boi, L; Carboni, E; Carta, AR; Fenu, S; Greig, NH; Mulas, G; Pisanu, A; Scerba, MT; Spiga, S; Tweedie, D	1

Other Studies

1 other study(ies) available for oxidopamine and 3,6'-dithiothalidomide

Article	Year
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:12 Topics: Angiogenesis Inhibitors; Animals; Antiparkinson Agents; Cytokines; Dyskinesia, Drug-Induced; Immunologic Factors; Interleukin-10; Levodopa; Male; Neostriatum; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Substantia Nigra; Thalidomide; Tumor Necrosis Factor-alpha	2019

Article

Year

Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:12

Topics: Angiogenesis Inhibitors; Animals; Antiparkinson Agents; Cytokines; Dyskinesia, Drug-Induced; Immunologic Factors; Interleukin-10; Levodopa; Male; Neostriatum; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Substantia Nigra; Thalidomide; Tumor Necrosis Factor-alpha

2019